Ubiquitination/ Proteasome
Ubiquitination/ Proteasome(泛素化/蛋白酶体)
Ubiquitination/ Proteasome 相关产品(1292)
- GC45187Zoledronic Acid (hydrate)CAS: 165800-06-6纯度: >98.00%
A bisphosphonate that inhibits bone resorption
- GC45828Ponatinib-d8CAS: 1562993-37-6纯度: >99.00%
An internal standard for the quantification of ponatinib
- GC45885Chloroquine-d5 (phosphate)CAS: 1854126-42-3纯度: >99.00%
An internal standard for the quantification of chloroquine
- GC46008(±)-Thalidomide-d4CAS: 1219177-18-0纯度: >99.00%
An internal standard for the quantification of (±)-thalidomide
- GC46792Ac-Nle-Pro-Nle-Asp-AMC (trifluoroacetate salt)纯度: >98.00%
A neuropeptide with diverse biological activities
- GC46989C18 dihydro Ceramide-d3 (d18:0/18:0-d3)CAS: 2699606-99-8纯度: >99.00%
An internal standard for the quantification of C18 dihydro ceramide
- GC47042Carfilzomib-d8CAS: 1537187-53-3纯度: >99.00%
An internal standard for the quantification of carfilzomib
- GC47193Desethyl Hydroxychloroquine-d4CAS: 1854126-47-8纯度: >99.00%
An internal standard for the quantification of desethyl hydroxychloroquine
- GC47195Desethylchloroquine-d4CAS: 1189971-72-9纯度: >99.00%
An internal standard for the quantification of desethylchloroquine
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC45099 | U-0126 | 109511-58-2 | >98.00% | |
A MEK inhibitor and AMPK activator | ||||
| GC45184 | Z-LLE-AMC | 348086-66-8 | >95.00% | |
Z-LLE-AMC是一种荧光底物，被特定的蛋白酶水解后，游离的AMC具有蓝色荧光（激发光为340-360nm，发射光为440-460nm），从而用于监测蛋白酶的活性水平。 | ||||
| GC45185 | Z-LLL-AMC | 152015-61-7 | >98.00% | |
A fluorogenic substrate for proteasomal chymotrypsin-like activity | ||||
| GC45187 | Zoledronic Acid (hydrate) | 165800-06-6 | >98.00% | |
A bisphosphonate that inhibits bone resorption | ||||
| GC45550 | Pogostone | 23800-56-8 | >98.00% | |
Pogostone是一种吡喃酮，是Pogostemonis Herba的精油制剂的主要成分。 | ||||
| GC45616 | C6 Urea Ceramide | 486991-52-0 | >95.00% | |
An inhibitor of neutral ceramidase | ||||
| GC45639 | Hexapeptide-11 (acetate) | - | >95.00% | |
A synthetic hexapeptide | ||||
| GC45719 | Gymnemic Acid I | 122168-40-5 | >98.00% | |
A triterpene glycoside | ||||
| GC45828 | Ponatinib-d8 | 1562993-37-6 | >99.00% | |
An internal standard for the quantification of ponatinib | ||||
| GC45885 | Chloroquine-d5 (phosphate) | 1854126-42-3 | >99.00% | |
An internal standard for the quantification of chloroquine | ||||
| GC46008 | (±)-Thalidomide-d4 | 1219177-18-0 | >99.00% | |
An internal standard for the quantification of (±)-thalidomide | ||||
| GC46057 | 2,5-Dihydroxycinnamic Acid phenethyl ester | 179691-97-5 | >98.00% | |
An inhibitor of 5-LO | ||||
| GC46792 | Ac-Nle-Pro-Nle-Asp-AMC (trifluoroacetate salt) | - | >98.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46897 | AUTEN-99 | 1049780-58-6 | >98.00% | |
An inhibitor of MRMR14/Jumpy | ||||
| GC46923 | Bexarotene-d4 | 2182068-00-2 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46942 | Bortezomib-d15 | - | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC46989 | C18 dihydro Ceramide-d3 (d18:0/18:0-d3) | 2699606-99-8 | >99.00% | |
An internal standard for the quantification of C18 dihydro ceramide | ||||
| GC47016 | Cabergoline-d6 | 2738376-76-4 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC47042 | Carfilzomib-d8 | 1537187-53-3 | >99.00% | |
An internal standard for the quantification of carfilzomib | ||||
| GC47065 | CAY10773 | 1648546-79-5 | >98.00% | |
A derivative of sorafenib | ||||
| GC47193 | Desethyl Hydroxychloroquine-d4 | 1854126-47-8 | >99.00% | |
An internal standard for the quantification of desethyl hydroxychloroquine | ||||
| GC47194 | Desethylchloroquine | 1476-52-4 | >95.00% / >99.00% | |
An active metabolite of chloroquine | ||||
| GC47195 | Desethylchloroquine-d4 | 1189971-72-9 | >99.00% | |
An internal standard for the quantification of desethylchloroquine | ||||
| GC47271 | D-Pyrohomoglutamic Acid | 72002-30-3 | >95.00% | |
A building block | ||||